is noom glp 1 legit offers cut-price compounded GLP-1 drug for obesity Noom launches full-page ad in

Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs

weight-loss | US $ 9.2 B global sales (2024) Source: Novo Nordisk Annual Report 2024 SAUDI GLP-1 MARKET US $103.3 M (2023) projected US $471.1 M by 2030 (24.2 % CAGR) Ozempic 51 % share | Wegovy launch 2025 Source: Grand View Research REGULATORY WATCH EMA reviewing potential link to NAION (optic neuropathy) Impact on oral-contraceptive efficacy under review Source: European Medicines Agency (EMA) One molecule, two markets both fuelling unprecedented growth in Saudi pharma

Similar to the gluten-free diet, the low-FODMAP diet also restricts gluten

An important factor in helping healthcare professionals and their patients decide on the best medication for the individual is determining patient preference on the frequency (daily vs